Case number 1:20-cv-00949
Merck Sharp & Dohme Corp. v. Aurobindo Pharma Limited et al > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Oct 7, 2021 | N/A | Redaction Notice (0) Docket Text: REDACTION NOTICE: In accordance with section G of the Administrative Procedures Governing Filing and Service by Electronic Means, redacted versions of sealed documents shall be filed electronically within 7 days of the filing of the sealed document. The records of this case do not reflect the filing of a redacted version of DI #[124]. (nms) |
| Oct 7, 2021 | 130 | Redacted Document (26) Docket Text: REDACTED VERSION of [124] Exhibit to a Document, by Merck Sharp & Dohme Corp.. (Joyce, Alexandra) Modified on 10/8/2021 (nms). |
| Sep 30, 2021 | N/A | Terminated Case (0) Docket Text: CASE CLOSED per D.I. [128]. (nms) |
| Sep 30, 2021 | 128 | Consent Judgment (3) Docket Text: CONSENT JUDGMENT between Aurobindo Pharma Limited, Aurobindo Pharma USA, Inc., and Merck Sharp & Dohme Corp.. Signed by Judge Richard G. Andrews on 9/30/2021. Associated Cases: 1:19-md-02902-RGA, 1:20-cv-00949-RGA, 1:20-cv-01099-RGA(nms) |
| Sep 30, 2021 | 129 | Main Document (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,326,708. (Attachments: # (1) Consent Judgment)(nms) |
| Sep 30, 2021 | 129 | Consent Judgment (3) |
| Sep 29, 2021 | N/A | CORRECTING ENTRY: (0) Docket Text: CORRECTING ENTRY: The pdf for the Stipulation and Proposed Order Regarding COVID-19 Protocols filed on 9/29/2021, has been replaced with an amended version. The case caption has been updated. Associated Cases: 1:19-cv-00319-RGA, 1:19-md-02902-RGA, 1:20-cv-00847-RGA, 1:20-cv-00949-RGA, 1:20-cv-01099-RGA(nms) |
| Sep 29, 2021 | 125 | Stipulation (4) Docket Text: STIPULATION and [Proposed] Order Regarding COVID-19 Protocols by Merck Sharp & Dohme Corp.. (Joyce, Alexandra) |
| Sep 29, 2021 | 126 | Order (4) Docket Text: SO ORDERED Granting (D.I. 125 in 20-cv-949-RGA; D.I. 204 in 19-cv-319-RGA; D.I. 611 in 19-md-2902-RGA; D.I. 110 in 20-cv-847-RGA: D.I. 130 in 20-cv-1099-RGA) Stipulation and Proposed Order Regarding COVID-19 Protocols. Signed by Judge Richard G. Andrews on 9/29/2021. Associated Cases: 1:19-md-02902-RGA, 1:19-cv-00319-RGA, 1:20-cv-00847-RGA, 1:20-cv-00949-RGA, 1:20-cv-01099-RGA(nms) |
| Sep 29, 2021 | 127 | Proposed Consent Judgment (3) Docket Text: PROPOSED Consent Judgment, by Merck Sharp & Dohme Corp.. (Joyce, Alexandra) Modified on 9/30/2021 (nms). |
| Sep 24, 2021 | 119 | Order (2) Docket Text: ORDER: Merck's request regarding obviousness-type double patenting (D.I. [586]) is DENIED. Signed by Judge Richard G. Andrews on 9/24/2021. Associated Cases: 1:19-md-02902-RGA et al.(nms) |
| Sep 24, 2021 | 120 | Stipulation (5) Docket Text: STIPULATION and [Proposed] Order Narrowing Disputes for Trial by Merck Sharp & Dohme Corp.. (Silver, Daniel) |
| Sep 24, 2021 | 121 | Order (5) Docket Text: SO ORDERED Granting (D.I. 597 in 19-md-2902-RGA; D.I. 191 in 19-cv-313-RGA; D.I. 181 in 19-cv-312-RGA; D.I. 199 in 19-cv-319-RGA; D.I. 120 in 20-cv-949-RGA: D.I. 105 in 20-cv-847-RGA; D.I. 127 in 20-cv-749-RGA; D.I. 125 in 20-cv-1099-RGA; D.I. 169 in 19-cv-314-RGA) Stipulation and Proposed Order Narrowing Disputes for Trial. Signed by Judge Richard G. Andrews on 9/24/2021. Associated Cases: 1:19-md-02902-RGA et al.(nms) |
| Sep 24, 2021 | 122 | Stipulation (4) Docket Text: STIPULATION and [Proposed] Order Regarding Pretrial Briefing by Merck Sharp & Dohme Corp.. (Silver, Daniel) |
| Sep 24, 2021 | 123 | Order (4) Docket Text: SO ORDERED Granting (D.I. 193 in 19-cv-313-RGA; D.I. 183 in 19-cv-312-RGA; D.I. 599 in 19-md-2902-RGA; D.I. 107 in 20-cv-847-RGA; D.I. 201 in 19-cv-319-RGA; D.I. 171 in 19-cv-314-RGA; D.I. 127 in 20-cv-1099-RGA; D.I. 122 in 20-cv-949-RGA; D.I. 129 in 20-cv-749-RGA) Stipulation and Proposed Order Regarding Pretrial Briefing. Signed by Judge Richard G. Andrews on 9/24/2021. Associated Cases: 1:19-md-02902-RGA et al.(nms) |
| Sep 23, 2021 | 116 | Letter (1) Docket Text: Letter to The Honorable Richard G. Andrews, from Daniel M. Silver, Esq., regarding the Court's September 22, 2021. (Silver, Daniel) Modified on 9/23/2021 (nms). |
| Sep 23, 2021 | 117 | Order (5) Docket Text: SO ORDERED Granting Stipulation and Proposed Order (see D.I. 120 in 20-cv-749-RGA; D.I. 588 in 19-md-2902-RGA; D.I. 118 in 20-cv-1099-RGA; D.I. 191 in 19-cv-319-RGA; D.I. 184 in 19-cv-313-RGA; D.I. 174 in 19-cv-312-RGA; D.I. 162 in 19-cv-314-RGA; D.I. 113 in 20-cv-949-RGA; D.I. 97 in 20-cv-847-RGA). Signed by Judge Richard G. Andrews on 9/23/2021. Associated Cases: 1:19-md-02902-RGA et al.(nms) |
| Sep 23, 2021 | 118 | Redacted Document (30) Docket Text: REDACTED VERSION of [111] Letter, by Merck Sharp & Dohme Corp.. (Joyce, Alexandra) Modified on 9/24/2021 (nms). |
| Sep 22, 2021 | N/A | Remark (0) Docket Text: Remark: The Bench Trial scheduled to start 10/4/2021, will now be held in Courtroom 4B. Associated Cases: 1:19-md-02902-RGA et al.(lak) Modified on 9/23/2021 (nms). |
| Sep 22, 2021 | N/A | Oral Order (0) Docket Text: ORAL ORDER: A join letter addressing whether paragraph 3 of the Stipulation (see D.I. 588 in 19md2902-RGA) is referencing anybody besides Dr. Buckton is due no later than 48 hour from the date of this Order. Ordered by Judge Richard G. Andrews on 9/22/2021. Associated Cases: 1:19-md-02902-RGA et al.(nms) |
| Sep 22, 2021 | 115 | Redacted Document (30) Docket Text: REDACTED VERSION of [102] Proposed Pretrial Order, by Merck Sharp & Dohme Corp.. (Silver, Daniel) Modified on 9/23/2021 (nms). |
| Sep 21, 2021 | 113 | Stipulation (5) Docket Text: STIPULATION and [Proposed] Order Regarding Trial Vendor for Remote Testimony and Viewing of Validity Bench Trial, by Merck Sharp & Dohme Corp.. (Joyce, Alexandra) Modified on 9/21/2021 (nms). |
| Sep 20, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (D.I. 119 in 20-cv-749-RGA; D.I. 112 in 20-cv-949-RGA: D.I. 183 in 19-cv-313-RGA; D.I. 173 in 19-cv-312-RGA; D.I. 190 in 19-cv-319-RGA; D.I. 587 in 19-md-2902-RGA; D.I. 96 in 20-cv-847-RGA; D.I. 161 in 19-cv-314-RGA; D.I. 117 in 20-cv-1099-RGA) STIPULATION TO EXTEND TIME to submit a public redacted version of the Proposed Joint Pretrial Order for Validity Trial to September 22, 2021. Signed by Judge Richard G. Andrews on 9/20/2021. Associated Cases: 1:19-md-02902-RGA et al.(nms) |
| Sep 17, 2021 | 112 | Stipulation to EXTEND Time (4) Docket Text: STIPULATION TO EXTEND TIME to submit a public redacted version of the Proposed Joint Pretrial Order for Validity Trial to September 22, 2021 - filed by Merck Sharp & Dohme Corp.. (Joyce, Alexandra) Modified on 9/20/2021 (nms). |
| Sep 15, 2021 | 108 | Main Document (3) Docket Text: STIPULATION and Proposed Order for Entry of Letter of Request for Judicial Assistance to Facilitate Remote Trial Testimony of Dr. Fabia Gozzo in Switzerland, by Merck Sharp & Dohme Corp.. (Attachments: # (1) Exhibit A)(Silver, Daniel) Modified on 9/15/2021 (nms). |
| Sep 15, 2021 | 108 | Exhibit A Appointment of Commissions (14) |
| Sep 15, 2021 | 109 | Order (3) Docket Text: SO ORDERED Granting (D.I. 113 in 20-cv-1099-RGA; D.I. 108 in 20-cv-949-RGA; 579 in D.I. 19-md-2902-RGA) Stipulation and Proposed Order for Entry of Letter of Request for Judicial Assistance to Facilitate Remote Trial Testimony of Dr. Fabia Gozzo in Switzerland. Signed by Judge Richard G. Andrews on 9/15/2021. Associated Cases: 1:19-md-02902-RGA, 1:20-cv-00949-RGA, 1:20-cv-01099-RGA(nms) |
| Sep 15, 2021 | 110 | Order (13) Docket Text: APPOINTMENT of Commissioners Under the Hague Convention and Request for Judicial Assistance. Signed by Judge Richard G. Andrews on 9/15/2021. Associated Cases: 1:19-md-02902-RGA, 1:20-cv-00949-RGA, 1:20-cv-01099-RGA(nms) |
| Sep 10, 2021 | N/A | Pretrial Conference (0) Docket Text: Minute Entry for proceedings held before Judge Richard G. Andrews - Pretrial Conference held on 9/10/2021. Counsel for Plaintiff: D. Silver, A. Joyce. Counsel for Defendants: A. Gaza, J. Phillips, E. Ormerod, D. Gattuso. A 3 day Bench Trial is set to begin on 10/4/2021 in Courtroom 6A. (Court Reporter Heather Triozzi.) Associated Cases: 1:19-md-02902-RGA et al. (lak) |
| Sep 10, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (D.I. 179 in 19-cv-313-RGA; D.I. 50 in 20-cv-1496-RGA: D.I. 111 in 20-cv-1099-RGA: D.I. 575 in 19-md-2902-RGA; D.I. 158 in 19-cv-314-RGA: 115 in 20-cv-749-RGA: 75 in 20-cv-815-RGA; D.I. 187 in 19-cv-319-RGA: D.I. 93 in 20-cv-847-RGA: D.I. 169 in 19-cv-312-RGA; D.I. 106 in 20-cv-949-RGA) STIPULATION TO EXTEND TIME the Deadline to Submit a Redacted Version of the Proposed Joint Pretrial Order to September 17, 2021. Signed by Judge Richard G. Andrews on 9/10/2021. Associated Cases: 1:19-cv-00312-RGA et al.(nms) |
| Sep 10, 2021 | 106 | Stipulation to EXTEND Time (4) Docket Text: STIPULATION and Proposed Order to Extend Time to Submit a Redacted Version of the Proposed Joint Pretrial Order to September 17, 2021 - filed by Merck Sharp & Dohme Corp.. (Joyce, Alexandra) Modified on 9/10/2021 (nms). |
| Sep 10, 2021 | 107 | Order (2) Docket Text: ORDER AFTER PRETRIAL CONFERENCE (see Order for further details). Signed by Judge Richard G. Andrews on 9/10/2021. Associated Cases: 1:19-md-02902-RGA et al.(nms) |
| Sep 9, 2021 | N/A | Remark (0) Docket Text: Remark: The public may access the hearing scheduled for 9/10/2021, at 8:15 a.m. by dialing the following phone number: +1 202-503-1666, then enter Conference ID: 258126659#. The dial-in information provides listening capabilities only. Associated Cases: 1:19-md-02902-RGA et al. (lak) |
| Sep 8, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (185 in 19-cv-319-RGA; 73 in 20-cv-815-RGA; 12 in 21-cv-824-RGA; 48 in 20-cv-1496-RGA; 156 in 19-cv-314-RGA; 572 in 19-md-2902-RGA; 104 in 20-cv-949-RGA; 6 in 21-cv-1172-RGA; 91 in 20-cv-847-RGA; 114 in 20-cv-749-RGA; 35 in 21-cv-315-RGA; 109 in 20-cv-1099-RGA; 167 in 19-cv-312-RGA; 8 in 21-cv-1173-RGA; 177 in 19-cv-313-RGA) MOTION for Pro Hac Vice Appearance of Attorney David M. Krinsky, filed by Merck Sharp & Dohme Corp.. Signed by Judge Richard G. Andrews on 9/8/2021. Associated Cases: 1:19-cv-00312-RGA et al.(nms) |
| Sep 8, 2021 | 104 | Main Document (2) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney David M. Krinsky - filed by Merck Sharp & Dohme Corp.. (Attachments: # (1) Certification for David M. Krinsky)(Silver, Daniel) |
| Sep 8, 2021 | 104 | Certification for David M. Krinsky (1) |
| Sep 8, 2021 | N/A | Oral Order (0) Docket Text: ORAL ORDER: The Pretrial Conference set for 9/10/2021 will now begin at 8:15 AM and will be held using Teams. A joint email with the email addresses for all those participating in the conference shall be due to the Court's Case Manager by 12:00 PM on 9/9/2021. Ordered by Judge Richard G. Andrews on 9/8/2021. Associated Cases: 1:19-md-02902-RGA et al.(lak) |
| Sep 7, 2021 | 103 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendants' Notice Pursuant to 35 U.S.C. ยง 282 [CONFIDENTIAL] filed by Sandoz Inc..(Gattuso, Dominick) |
| Aug 23, 2021 | 101 | Order (3) Docket Text: STATMENT: Regarding impasse on "Statement of Contested Issues of Fact" for inclusion in the proposed pretrial order (see Statement for further details). Signed by Judge Richard G. Andrews on 8/23/2021. (nms) |
| Aug 19, 2021 | 99 | Letter (2) Docket Text: Letter to The Honorable Richard G. Andrews from Daniel M. Silver, Esq. regarding the Submission of the Pretrial Order. (Silver, Daniel) |
| Aug 19, 2021 | 100 | Letter (2) Docket Text: Letter to The Honorable Richard G. Andrews, from Dominick T. Gattuso, Esq., responding to Merck's Letter. (Gattuso, Dominick) Modified on 8/21/2021 (nms). |
| Aug 11, 2021 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Vanessa O. Omoroghomwan for Merck Sharp & Dohme Corp. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. Associated Cases: 1:20-cv-00847-RGA et al.(srs) |
| Aug 5, 2021 | 98 | Notice of Appearance (1) Docket Text: NOTICE of Appearance by Julie M. O'Dell on behalf of Aurobindo Pharma USA Inc., Aurobindo Pharma, Ltd., Aurobindo Pharma Limited, Aurobindo Pharma USA, Inc. (O'Dell, Julie) |
| Aug 2, 2021 | 96 | Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of Ralph Tarantino, R.Ph., Ph.D. on August 9, 2021 at 9:00 am ET filed by Merck Sharp & Dohme Corp..(Joyce, Alexandra) |
| Aug 2, 2021 | 97 | Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of Joseph H. Reibenspies, Ph.D. on August 13, 20210 at 9:00 am ET filed by Merck Sharp & Dohme Corp..(Joyce, Alexandra) |
| Jul 29, 2021 | 92 | Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of Allan S. Myerson on August 11, 2021 at 9:00 a.m. filed by Aurobindo Pharma USA Inc., Aurobindo Pharma, Ltd., Aurobindo Pharma Limited, Aurobindo Pharma USA, Inc..(Ormerod, Eve) |
| Jul 29, 2021 | 93 | Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of Dr. Fabia Gozzo on August 30, 2021 at 3:00 a.m. EST filed by Aurobindo Pharma USA Inc., Aurobindo Pharma, Ltd., Aurobindo Pharma Limited, Aurobindo Pharma USA, Inc..(Ormerod, Eve) |
| Jul 29, 2021 | 94 | Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of Stephen R. Little on August 6, 2021 at 9:00 a.m. EST filed by Aurobindo Pharma USA Inc., Aurobindo Pharma, Ltd., Aurobindo Pharma Limited, Aurobindo Pharma USA, Inc..(Ormerod, Eve) |
| Jul 29, 2021 | 95 | Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of Dr. G. Patrick Stahly on August 3, 2021 at 9:00 a.m. EST filed by Aurobindo Pharma USA Inc., Aurobindo Pharma, Ltd., Aurobindo Pharma Limited, Aurobindo Pharma USA, Inc..(Ormerod, Eve) |
| Jul 20, 2021 | 91 | Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of Leonard J. Chyall, Ph. D. on July 23, 2021 filed by Merck Sharp & Dohme Corp..(Silver, Daniel) |
| Jul 19, 2021 | 90 | Notice to Take Deposition (6) Docket Text: NOTICE to Take Deposition of David MacMillan on July 21, 2021 at 10:00 a.m. EST filed by Aurobindo Pharma USA Inc., Aurobindo Pharma, Ltd., Aurobindo Pharma Limited, Aurobindo Pharma USA, Inc..(Ormerod, Eve) |
| Jul 12, 2021 | 89 | Notice (Other) (2) Docket Text: NOTICE of Remote Deposition of Graham Buckton, Ph.D. by Merck Sharp & Dohme Corp. (Silver, Daniel) |
| Jul 9, 2021 | 88 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Responses and Objections to the Second Set of Requests for Production and the Second Set of Interrogatories from Plaintiff Merck Sharp & Dohme Corp. filed by Aurobindo Pharma USA Inc., Aurobindo Pharma, Ltd., Aurobindo Pharma Limited, Aurobindo Pharma USA, Inc..(Ormerod, Eve) |
| Jul 8, 2021 | 87 | Notice to Take Deposition (7) Docket Text: NOTICE to Take Deposition of Allan Myerson on July 13, 2021 at 9:00 am EST filed by Aurobindo Pharma USA Inc., Aurobindo Pharma, Ltd., Aurobindo Pharma Limited, Aurobindo Pharma USA, Inc..(Ormerod, Eve) |
| Jul 2, 2021 | N/A | Status Conference (0) Docket Text: Minute Entry for proceedings held before Judge Richard G. Andrews - T/C Status Conference held on 7/2/2021. Counsel for Plaintiffs: A. Joyce, A. Gaza, E. Ormerod. Counsel for Defendants: K. Dorsney, J. Phillips, D. Gattuso. The 9/10/2021 pretrial conference shall cover invalidity only. A separate pretrial conference will be scheduled to cover infringement. (Court Reporter Stacy Ingram.) Associated Cases: 1:19-md-02902-RGA et al.(lak) |
| Jul 2, 2021 | N/A | Oral Order (0) Docket Text: ORAL ORDER: The 9/10/2021 pretrial conference will cover invalidity only. A separate pretrial conference will be scheduled to cover infringement. Ordered by Judge Richard G. Andrews on 7/2/2021. Associated Cases: 1:19-md-02902-RGA et al. (lak) |
| Jul 2, 2021 | 83 | Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of Zachary T. Bloomgarden on August 6, 2021 at 9:00 a.m. EST filed by Aurobindo Pharma USA Inc., Aurobindo Pharma, Ltd., Aurobindo Pharma Limited, Aurobindo Pharma USA, Inc..(Ormerod, Eve) |
| Jul 2, 2021 | 84 | Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of Stephen R. Little on July 14, 2021 at 9:00 a.m. EST filed by Aurobindo Pharma USA Inc., Aurobindo Pharma, Ltd., Aurobindo Pharma Limited, Aurobindo Pharma USA, Inc..(Ormerod, Eve) |
| Jul 2, 2021 | 85 | Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of Allan S. Myerson on August 3, 2021 at 9:00 a.m. EST filed by Aurobindo Pharma Limited, Aurobindo Pharma USA, Inc..(Ormerod, Eve) |
| Jul 2, 2021 | 86 | Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of Fabia Gozzo on July 12, 2021 at 9:00 a.m. EST filed by Aurobindo Pharma USA Inc., Aurobindo Pharma, Ltd., Aurobindo Pharma Limited, Aurobindo Pharma USA, Inc..(Ormerod, Eve) |
| Jul 1, 2021 | 81 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of (1) Reply Expert Report of Allan S. Myerson, Ph.D. Regarding Aurobindo's Infringement of U.S. Patent No. 7,326,708; (2) Reply Report of G. Patrick Stahly, Ph.D. Regarding Aurobindo's Samples; (3) Reply Expert Report of Fabia Gozzo, Ph.D. Regarding S-XRPD Testing of Aurobindo Samples; (4) Reply Expert Report of Steven R. Little, Ph.D. Regarding Aurobindo's Infringement of U.S. Patent No. 8,414,921 filed by Merck Sharp & Dohme Corp..(Silver, Daniel) |
| Jun 29, 2021 | 80 | Letter (1) Docket Text: Letter to The Honorable Richard G. Andrews, from Daniel M. Silver, Esq., regarding dial-in information for July 2, 2021 status conference. (Silver, Daniel) Modified on 6/30/2021 (nms). |
| Jun 28, 2021 | 79 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of (1) Second Set of Requests for Production and Second Set of Interrogatories from Plaintiff Merck Sharp & Dohme Corp. to Defendants Aurobindo Pharma Limited and Aurobindo Pharma USA, Inc., and (2) Second Notice of Deposition Pursuant to Federal Rule of Civil Procedure 30(b)(6) from Plaintiff Merck Sharp & Dohme Corp. to Defendants Aurobindo Pharma Limited and Aurobindo Pharma USA, Inc. filed by Merck Sharp & Dohme Corp..(Silver, Daniel) |
| Jun 24, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (75 in 20-cv-847-RGA; 36 in 20-cv-1496-RGA; 96 in 20-cv-749-RGA; 166 in 19-cv-319-RGA; 78 in 20-cv-949-RGA; 82 in 20-cv-1099-RGA; 144 in 19-cv-314-RGA; 163 in 19-cv-313-RGA; 30 in 21-cv-315-RGA; 189 in 19-cv-1489-RGA; 10 in 21-cv-824-RGA; 155 in 19-cv-312-RGA; 61 in 20-cv-815-RGA) MOTION for Pro Hac Vice Appearance of Attorney Vanessa O. Omoroghomwan, filed by Merck Sharp & Dohme Corp.. Signed by Judge Richard G. Andrews on 6/24/2021. Associated Cases: 1:19-cv-00312-RGA et al.(nms) |
| Jun 24, 2021 | 78 | Main Document (2) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Vanessa O. Omoroghomwan - filed by Merck Sharp & Dohme Corp.. (Attachments: # (1) Certification for Vanessa O. Omoroghomwan)(Silver, Daniel) |
| Jun 24, 2021 | 78 | Certification for Vanessa O. Omoroghomwan (1) |
| Jun 15, 2021 | 77 | Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of S. Craig Dyar, Ph.D. on June 18, 2021 filed by Merck Sharp & Dohme Corp..(Silver, Daniel) |
| Jun 7, 2021 | 76 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of (i) Defendants' Reply Expert Report of Leonard J. Chyall, Ph.D. Concerning Invalidity of Claims 1-3, 17, 19, and 21-23 of U.S. Patent No. 7,326,70 [CONFIDENTIAL]; and (ii) the Reply Expert Report of Graham Buckton, Ph.D., D.Sc. [CONFIDENTIAL] filed by Sandoz Inc..(Gattuso, Dominick) |
| Jun 2, 2021 | 75 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of 1) Expert Opinion of Joseph H. Reibenspies, Ph.D. and 2) Responsive Expert Report of Ralph Tarantino, R.Ph., Ph.D., in Response to the Opening Expert Report of Steven Little, Ph.D., re: U.S. Patent No. 8,414,921, and Zachary Bloomgarden re: U.S. Patent Nos. 8,414,921 and 7,326,708 filed by Aurobindo Pharma USA Inc., Aurobindo Pharma, Ltd., Aurobindo Pharma Limited, Aurobindo Pharma USA, Inc..(Ormerod, Eve) |
| May 28, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, Granting (78 in 20-cv-1099-RGA; 74 in 20-cv-949-RGA; 485 in 19-md-2902-RGA) STIPULATION TO EXTEND TIME to Submit Responsive Infringement Reports to May 28, 2021. Signed by Judge Richard G. Andrews on 5/28/2021. Associated Cases: 1:19-md-02902-RGA, 1:20-cv-00949-RGA, 1:20-cv-01099-RGA(nms) |
| May 26, 2021 | 74 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME to Submit Responsive Infringement Reports to May 28, 2021 - filed by Aurobindo Pharma USA Inc., Aurobindo Pharma, Ltd., Aurobindo Pharma Limited, Aurobindo Pharma USA, Inc.. (Ormerod, Eve) |
| May 25, 2021 | 73 | Notice Requesting Removal of Co-Counsel (1) Docket Text: NOTICE requesting Clerk to remove Jeffrey Ho as co-counsel.. (Silver, Daniel) |
| May 11, 2021 | 72 | Main Document (1) Docket Text: Letter to The Honorable Richard G. Andrews from Daniel M. Silver, Esq. regarding IPR Decision. (Attachments: # (1) IPR Decision)(Silver, Daniel) |
| May 11, 2021 | 72 | IPR Decision (77) |
| May 7, 2021 | 71 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of (1) Opening Expert Report of Allan S. Myerson, Ph.D. Regarding Aurobindo's Infringement of U.S. Patent No. 7,326,708; (2) Opening Expert Report of Steven R. Little, Ph.D. Regarding Aurobindo's Infringement of U.S. Patent No. 8,414,921; (3) Expert Report of Zachary T. Bloomgarden, M.D. Regarding Aurobindo's Infringement; (4) Expert Report of Fabia Gozzo, Ph.D. Regarding S-XRPD Testing of Aurobindo Samples; and (5) Report of G. Patrick Stahly, Ph.D. Regarding Aurobindo's Samples filed by Merck Sharp & Dohme Corp..(Joyce, Alexandra) |
| May 3, 2021 | 70 | Notice (Other) (1) Docket Text: NOTICE of Joinder of Defendants Mylan Pharmaceuticals Inc. and Sun Pharmaceutical Industries Ltd's Opening Expert Report of S. Craig Dyar on Invalidity of U.S. Patent No. 8,414,921 by Aurobindo Pharma USA Inc., Aurobindo Pharma, Ltd., Aurobindo Pharma Limited, Aurobindo Pharma USA, Inc. (Ormerod, Eve) |
| Apr 29, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (D.I. 469 in 19-md-2902-RGA; D.I. 73 in 20-cv-1099-RGA; D.I. 69 in 20-cv-949-RGA) STIPULATION and Proposed Order to Extend Time for various deadlines. Signed by Judge Richard G. Andrews on 4/29/2021. Associated Cases: 1:19-md-02902-RGA, 1:20-cv-00949-RGA, 1:20-cv-01099-RGA(nms) |
| Apr 29, 2021 | 69 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION and Proposed Order to Extend Time - filed by Merck Sharp & Dohme Corp.. (Joyce, Alexandra) Modified on 4/29/2021 (nms). |
| Apr 19, 2021 | 68 | Notice of Service (10) Docket Text: NOTICE OF SERVICE of (1) Responsive Report of Zachary T. Bloomgarden, M.D. Regarding Validity; (2) Responsive Report of David MacMillan, Ph.D. Regarding Validity; (3) Responsive Expert Report of Allan S. Myerson, Ph.D. Regarding the Validty of U.S. Patent No. 7,326,708; (4) Responsive Report of Adam J. Matzger, Ph.D. Regarding Validity of the 708 Patent; and (5) Confidential Addendum to the Responsive Expert Report of Allan S. Myerson, Ph.D. Regarding the Validity of U.S. Patent No. 7,326,708 filed by Merck Sharp & Dohme Corp..(Joyce, Alexandra) |
| Apr 13, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, Granting (D.I. 67 in 20-cv-949-RGA; D.I. 71 in 20-cv-1099-RGA; D.I. 451 in 19-md-2902-RGA) STIPULATION and Proposed Order to Extend Time. Signed by Judge Richard G. Andrews on 4/13/2021. Associated Cases: 1:19-md-02902-RGA, 1:20-cv-00949-RGA, 1:20-cv-01099-RGA(nms) |
| Apr 13, 2021 | 67 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION and Proposed Order to Extend Time - filed by Merck Sharp & Dohme Corp.. (Joyce, Alexandra) Modified on 4/13/2021 (nms). |
| Mar 31, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (70 in 20-cv-1099-RGA; 66 in 20-cv-949-RGA; 445 in 19-md-2902-RGA) STIPULATION and Proposed Order for Extension of Time for the close of Fact Discovery and to Serve Supplemental Infringement Contentions to April 16, 2021. Signed by Judge Richard G. Andrews on 3/31/2021. Associated Cases: 1:19-md-02902-RGA, 1:20-cv-00949-RGA, 1:20-cv-01099-RGA(nms) |
| Mar 31, 2021 | 66 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION and Proposed Order for Extension of Time for the close of Fact Discovery and to Serve Supplemental Infringement Contentions to April 16, 2021 - filed by Merck Sharp & Dohme Corp.. (Joyce, Alexandra) Modified on 3/31/2021 (nms). |
| Mar 22, 2021 | 65 | Notice (Other) (1) Docket Text: NOTICE of Joinder by Aurobindo Pharma USA Inc., Aurobindo Pharma, Ltd., Aurobindo Pharma Limited, Aurobindo Pharma USA, Inc. (Ormerod, Eve) |
| Mar 3, 2021 | 63 | Stipulation (5) Docket Text: STIPULATION and [Proposed] Order Regarding Corrected Asserted Claims by Merck Sharp & Dohme Corp.. (Joyce, Alexandra) |
| Mar 3, 2021 | 64 | Order (5) Docket Text: SO ORDERED Granting (63 in 20-cv-949-RGA; 63 in 20-cv-847-RGA; 416 in 19-md-2902-RGA; 151 in 19-cv-313-RGA; 138 in 19-cv-314-RGA; 177 in 19-cv-1489-RGA; 30 in 20-cv-1496-RGA; 68 in 20-cv-749-RGA; 65 in 20-cv-1099-RGA; 143 in 19-cv-312-RGA; 55 in 20-cv-815-RGA; 151 in 19-cv-319-RGA) Stipulation and Proposed Order Regarding Corrected Asserted Claims. Signed by Judge Richard G. Andrews on 3/3/2021. Associated Cases: 1:19-cv-00312-RGA et al.(nms) |
| Feb 25, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (D.I. 62 in 20-cv-949-RGA; D.I. 64 in 20-cv-1099-RGA; D.I. 409 in 19-md-2902-RGA) STIPULATION and Proposed Order to Extend Time. Signed by Judge Richard G. Andrews on 2/25/2021. Associated Cases: 1:19-md-02902-RGA, 1:20-cv-00949-RGA, 1:20-cv-01099-RGA(nms) |
| Feb 24, 2021 | 61 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Plaintiff's Responses and Objections to Defendant Aurobindo Pharma Limited and Aurobindo Pharma USA, Inc.'s First Set of Interrogatories (Nos. 1-8) filed by Merck Sharp & Dohme Corp..(Joyce, Alexandra) |
| Feb 24, 2021 | 62 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION and Proposed Order to Extend Time - filed by Merck Sharp & Dohme Corp.. (Joyce, Alexandra) Modified on 2/25/2021 (nms). |
| Feb 22, 2021 | 60 | Notice of Service (5) Docket Text: NOTICE OF SERVICE of All Defendants' Opening Expert Report of Graham Buckton, Ph.D., D.Sc. filed by Sandoz Inc..(Gattuso, Dominick) |
| Feb 19, 2021 | 59 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Opening Expert Report of Leonard J. Chyall, Ph.D. Concerning Invalidity of Claims 1-3, 17, 19 and 21-23 of U.S. Patent No. 7,326,708 filed by Anchen Pharmaceuticals, Inc., Par Pharmaceuticals, Inc..(Mowery, Katharine) |
| Feb 15, 2021 | 58 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Plaintiff's Responses and Objections to Defendant Aurobindo Pharma USA Inc.'s and Aurobindo Pharma Ltd.'s Notice of Deposition Under Rule 30(b)(6) filed by Merck Sharp & Dohme Corp..(Joyce, Alexandra) |
| Feb 10, 2021 | 57 | Main Document (1) Docket Text: Letter to The Honorable Richard G. Andrews from Daniel M. Silver, Esq. regarding Certificate of Correction. (Attachments: # (1) Certificate of Correction)(Silver, Daniel) |
| Feb 10, 2021 | 57 | Certificate of Correction (1) |
| Feb 9, 2021 | 56 | Redacted Document (9) Docket Text: REDACTED VERSION of [54] Notice to Take Deposition, by Aurobindo Pharma USA Inc., Aurobindo Pharma, Ltd., Aurobindo Pharma Limited, Aurobindo Pharma USA, Inc.. (Ormerod, Eve) Modified on 2/9/2021 (nms). |
| Feb 5, 2021 | 55 | Notice (Other) (2) Docket Text: NOTICE of Depositions by Merck Sharp & Dohme Corp. (Joyce, Alexandra) |
| Jan 28, 2021 | 53 | Letter (3) Docket Text: Letter to The Honorable Richard G. Andrews, from Daniel M. Silver, Esq., regarding certificate of correction. (Silver, Daniel) Modified on 1/28/2021 (nms). |
| Jan 26, 2021 | 52 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of First Set of Interrogatories to Plaintiff Merck Sharp & Dohme Corp. filed by Aurobindo Pharma USA Inc., Aurobindo Pharma, Ltd., Aurobindo Pharma Limited, Aurobindo Pharma USA, Inc..(Ormerod, Eve) |
| Jan 25, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (23 in 20-cv-1496-RGA; 51 in 20-cv-949-RGA; 374 in 19-md-2902-RGA; 138 in 19-cv-312-RGA; 54 in 20-cv-847-RGA; 141 in 19-cv-319-RGA; 50 in 20-cv-815-RGA; 52 in 20-cv-749-RGA; 144 in 19-cv-313-RGA; 148 in 19-cv-311-RGA; 170 in 19-cv-1489-RGA; 64 in 20-cv-776-RGA; 132 in 19-cv-314-RGA; 142 in 19-cv-347-RGA; 50 in 20-cv-1099-RGA) MOTION for Pro Hac Vice Appearance of Attorney Jeffrey Ho, filed by Merck Sharp & Dohme Corp.. Signed by Judge Richard G. Andrews on 1/25/2021. Associated Cases: 1:19-cv-00311-RGA et al.(nms) |
| Jan 25, 2021 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Jeffrey G. Ho for Merck Sharp & Dohme Corp. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. Associated Cases: 1:19-md-02902-RGA et al.(kmd) |
| Jan 22, 2021 | 50 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Notice of Deposition Pursuant to Federal Rule of Civil Procedure 30(b)(6) filed by Merck Sharp & Dohme Corp..(Silver, Daniel) |
| Jan 22, 2021 | 51 | Main Document (2) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Jeffrey Ho - filed by Merck Sharp & Dohme Corp.. (Attachments: # (1) Certification of Jeffrey Ho)(Silver, Daniel) |
| Jan 22, 2021 | 51 | Certification of Jeffrey Ho (1) |
| Jan 15, 2021 | 49 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Plaintiff's Responses and Objections to Aurobindo Pharma Limited and Aurobindo Pharma USA, Inc.'s First Set of Requests for the Production of Documents and Things (Nos. 1-21) filed by Merck Sharp & Dohme Corp..(Joyce, Alexandra) |
| Jan 11, 2021 | 48 | Order (2) Docket Text: TRIAL SCHEDULING ORDER: Bench trials with Plaintiff and Defendants Ajanta (C.A. 20-1496-RGA), Apotex (C.A. 19-313-RGA; 20cv749-RGA) and Aurobindo (C.A. 20-949-RGA; C.A. 20-1099-RGA) are set to start at 8:30 am on November 22, 2021, and end on November 24, 2021. The exact order for which case will be proceeding first, second, and third is yet to be determined. Bench trials with Plaintiff and Defendants Dr. Reddys (C.A. 20-847-RGA), Lupin (C.A. 19-347-RGA; C.A. 20-776-RGA) and Zydus (C.A. 19-314-RGA) are set to start at 8:30 am on December 27, 2021, and end on December 29, 2021. The exact order for which case will be proceeding first, second, and third is yet to be determined. A bench trial between Plaintiff and Defendant Sun (C.A. 19-319-RGA) will start at 8:30 am on January 3, 2022, and conclude on January 4, 2022. A telephone status conference is set for July 2, 2021, at 8:30 am. Plaintiffs local counsel shall coordinate the call and file the dial-in information no later than 48 hours before the conference. Signed by Judge Richard G. Andrews on 1/11/2021. Associated Cases: 1:19-cv-00311-RGA et al.(nms) Modified on 1/12/2021 (nms). |
| Jan 8, 2021 | 47 | Letter (2) Docket Text: Letter to The Honorable Richard G. Andrews, from Daniel M. Silver, Esq., regarding a status update regarding infringement trials. (Silver, Daniel) Modified on 1/8/2021 (nms). |
| Jan 4, 2021 | 46 | Letter (1) Docket Text: Letter to The Honorable Richard G. Andrews, from Daniel M. Silver, Esq., regarding certificate of correction. (Silver, Daniel) Modified on 1/4/2021 (nms). |
| Dec 23, 2020 | 45 | Letter (1) Docket Text: Letter to The Honorable Richard G. Andrews from Daniel M. Silver, Esq. , regarding certificate of correction. (Silver, Daniel) Modified on 12/23/2020 (nms). |
| Dec 22, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (D.I. 43 in 20-cv-1099-RGA; D.I. 44 in 20-cv-949-RGA; D.I. 359 in 19-md-2902-RGA) STIPULATION TO EXTEND TIME for Substantial Completion of Document Production to January 21, 2021. Signed by Judge Richard G. Andrews on 12/22/2020. Associated Cases: 1:19-md-02902-RGA, 1:20-cv-00949-RGA, 1:20-cv-01099-RGA(nms) |
| Dec 22, 2020 | 44 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION and Proposed Order to Extend Time for Substantial Completion of Document Production to January 21, 2021 - filed by Aurobindo Pharma USA Inc., Aurobindo Pharma, Ltd., Aurobindo Pharma Limited, Aurobindo Pharma USA, Inc.. (Ormerod, Eve) Modified on 12/22/2020 (nms). |
| Dec 17, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (136 in 19-cv-347-RGA; 59 in 20-cv-776-RGA; 42 in 20-cv-1099-RGA; 45 in 20-cv-815-RGA; 46 in 20-cv-749-RGA; 143 in 19-cv-311-RGA; 43 in 20-cv-949-RGA; 132 in 19-cv-312-RGA; 139 in 19-cv-313-RGA; 126 in 19-cv-314-RGA; 165 in 19-cv-1489-RGA; 136 in 19-cv-319-RGA; 351 in 19-md-2902-RGA) STIPULATION and Proposed Order to Extend Time. Signed by Judge Richard G. Andrews on 12/17/2020. Associated Cases: 1:19-cv-00311-RGA et al.(nms) |
| Dec 17, 2020 | 43 | Stipulation to EXTEND Time (5) Docket Text: STIPULATION and Proposed Order to Extend Time - filed by Merck Sharp & Dohme Corp.. (Joyce, Alexandra) Modified on 12/17/2020 (nms). |
| Dec 16, 2020 | 42 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of First Set of Requests for Documents and Things (Nos. 1-21) to Plaintiff Merck Sharp & Dohme Corp. filed by Aurobindo Pharma USA Inc., Aurobindo Pharma, Ltd., Aurobindo Pharma Limited, Aurobindo Pharma USA, Inc..(Ormerod, Eve) |
| Dec 1, 2020 | 41 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of 1) Aurobindo's Responses and Objections to Plaintiff's First Set of Interrogatories and 2) Aurobindo's Responses and Objections to Plaintiff's First Set of Requests for Production filed by Aurobindo Pharma USA Inc., Aurobindo Pharma, Ltd., Aurobindo Pharma Limited, Aurobindo Pharma USA, Inc..(Ormerod, Eve) |
| Nov 24, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (40 in 20-cv-949-RGA; 332 in 19-md-2902-RGA; 39 in 20-cv-1099-RGA) STIPULATION and Proposed Order to Extend Time. Signed by Judge Richard G. Andrews on 11/24/2020. Associated Cases: 1:20-cv-00949-RGA, 1:19-md-02902-RGA, 1:20-cv-01099-RGA(nms) |
| Nov 24, 2020 | 40 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION and Proposed Order to Extend Time - filed by Merck Sharp & Dohme Corp.. (Joyce, Alexandra) Modified on 11/24/2020 (nms). |
| Nov 23, 2020 | 39 | Order (9) Docket Text: SO ORDERED Granting Stipulation and Proposed Order Regarding Authenticity of Documents. Signed by Judge Richard G. Andrews on 11/23/2020. Associated Cases: 1:19-cv-00311-RGA et al.(nms) |
| Nov 20, 2020 | 37 | Notice (Other) (1) Docket Text: NOTICE of Withdrawal of Certain Delaware Counsel by Aurobindo Pharma USA Inc., Aurobindo Pharma, Ltd., Aurobindo Pharma Limited, Aurobindo Pharma USA, Inc. (Ormerod, Eve) |
| Nov 20, 2020 | 38 | Stipulation (9) Docket Text: STIPULATION and Proposed Order Regarding Authenticity of Documents, by Merck Sharp & Dohme Corp.. (Joyce, Alexandra) Modified on 11/23/2020 (nms). |
| Nov 12, 2020 | N/A | CORRECTING ENTRY: (0) Docket Text: CORRECTING ENTRY: The redacted document filed at D.I. 33 has been removed from the docket as it was not linked to the sealed filing it is related to. (nms) |
| Nov 12, 2020 | 34 | Redacted Document (27) Docket Text: REDACTED VERSION of [32] Notice of Service, by Merck Sharp & Dohme Corp.. (Joyce, Alexandra) Modified on 11/13/2020 (nms). |
| Nov 12, 2020 | 35 | Redacted Document (29) Docket Text: REDACTED VERSION of [29] Notice of Service, by Merck Sharp & Dohme Corp.. (Joyce, Alexandra) Modified on 11/13/2020 (nms). |
| Nov 12, 2020 | 36 | Redacted Document (20) Docket Text: REDACTED VERSION of [30] Notice of Service, by Merck Sharp & Dohme Corp.. (Joyce, Alexandra) Modified on 11/13/2020 (nms). |
| Nov 6, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (32 in 20-cv-847-RGA; 48 in 20-cv-776-RGA; 293 in 19-md-2902-RGA; 116 in 19-cv-314-RGA; 31 in 20-cv-949-RGA; 126 in 19-cv-313-RGA; 121 in 19-cv-319-RGA; 35 in 20-cv-815-RGA; 30 in 20-cv-1099-RGA; 16 in 20-cv-1227-RGA; 183 in 19-cv-318-RGA; 124 in 19-cv-311-RGA; 123 in 19-cv-347-RGA; 149 in 19-cv-1489-RGA; 149 in 19-cv-317-RGA; 34 in 20-cv-749-RGA; 120 in 19-cv-312-RGA) MOTION for Pro Hac Vice Appearance of Attorney Sarahi Uribe. Signed by Judge Richard G. Andrews on 11/6/2020. Associated Cases: 1:19-cv-00311-RGA et al.(nms) |
| Nov 6, 2020 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Sarahi Uribe for Merck Sharp & Dohme Corp. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. Associated Cases: 1:19-md-02902-RGA et al. (kmd) |
| Nov 6, 2020 | 31 | Main Document (2) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Sarahi Uribe - filed by Merck Sharp & Dohme Corp.. (Attachments: # (1) Certification for Sarahi Uribe)(Silver, Daniel) |
| Nov 6, 2020 | 31 | Certification for Sarahi Uribe (1) |
| Nov 4, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (123 in 19-cv-313-RGA; 146 in 19-cv-317-RGA; 45 in 19-cv-00347-RGA; 119 in 19-cv-311-RGA; 283 in 19-md-2902-RGA; 117 in 19-cv-312-RGA; 180 in 19-cv-318-RGA; 28 in 20-cv-949-RGA; 27 in 20-cv-1099-RGA; 31 in 20-cv-749-RGA; 28 in 20-cv-815-RGA; 118 in 19-cv-00319-RGA; 29 in 20-cv-847-RGA; 113 in 19-cv-314-RGA) MOTION for Pro Hac Vice Appearance of Attorney Jihad Komis, filed by Merck Sharp & Dohme Corp.. Signed by Judge Richard G. Andrews on 11/4/2020. Associated Cases: 1:19-cv-00311-RGA et al.(nms) |
| Nov 4, 2020 | 28 | Main Document (2) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Jihad Komis - filed by Merck Sharp & Dohme Corp.. (Attachments: # (1) Certification for Jihad Komis)(Silver, Daniel) |
| Nov 4, 2020 | 28 | Certification for Jihad Komis (1) |
| Oct 30, 2020 | 25 | Joinder (2) Docket Text: Notice of Joinder, by Aurobindo Pharma USA Inc., Aurobindo Pharma, Ltd., Aurobindo Pharma Limited, Aurobindo Pharma USA, Inc..(Ormerod, Eve) Modified on 10/30/2020 (nms). |
| Oct 30, 2020 | 26 | Order Setting Teleconference (4) Docket Text: ORDER Setting Teleconference: A Telephone Conference is set for 12/18/2020 at 11:00 AM Eastern Time with Judge Mary Pat Thynge to discuss ADR. Plaintiffs' counsel to initiate the call. Signed by Judge Mary Pat Thynge on 10/30/20. Associated Cases: 1:20-cv-00949-RGA, 1:20-cv-01099-RGA(cak) |
| Oct 30, 2020 | 27 | Letter (1) Docket Text: Letter to The Honorable Richard G. Andrews from Daniel M. Silver regarding Certificate of Correction. (Silver, Daniel) |
| Oct 27, 2020 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorneys Steven J. Moore and James E. Nealon for Aurobindo Pharma USA Inc. and Aurobindo Pharma, Ltd. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. Associated Cases: 1:20-cv-01099-RGA, 1:19-md-02902-RGA, 1:20-cv-00949-RGA(kmd) |
| Oct 27, 2020 | 24 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of (1) First Set of Requests for Production from Plaintiff Merck Sharp & Dohme Corp. to Defendants Aurobindo Pharma Limited and Aurobindo Pharma USA, Inc.; and (2) First Set of Interrogatories from Plaintiff Merck Sharp & Dohme Corp. to Defendants Aurobindo Pharma Limited and Aurobindo Pharma USA, Inc. filed by Merck Sharp & Dohme Corp..(Silver, Daniel) |
| Oct 9, 2020 | 22 | Notice of Service (4) Docket Text: NOTICE OF SERVICE of Initial Infringement Contentions of Plaintiff Merck Sharp & Dohme Corp. filed by Merck Sharp & Dohme Corp..(Silver, Daniel) |
| Oct 9, 2020 | 23 | Notice of Service (10) Docket Text: NOTICE OF SERVICE of Plaintiff Merck Sharp & Dohme Corp.s Third Supplemental Responses and Objections to Defendants First Set of Joint Interrogatories (Nos. 1-10) filed by Merck Sharp & Dohme Corp..(Silver, Daniel) |
| Oct 8, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (21 in 20-cv-949-RGA; 20 in 20-cv-1099-RGA; 246 in 19-md-2902-RGA) MOTION for Pro Hac Vice Appearance of Attorney Steven J. Moore and James E. Nealon, filed by Aurobindo Pharma USA, Inc., Aurobindo Pharma Limited, Aurobindo Pharma, Ltd., Aurobindo Pharma USA Inc.. Signed by Judge Richard G. Andrews on 10/8/2020. Associated Cases: 1:19-md-02902-RGA, 1:20-cv-00949-RGA, 1:20-cv-01099-RGA(nms) |
| Oct 8, 2020 | 21 | Motion for Leave to Appear Pro Hac Vice (4) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Steven J. Moore and James E. Nealon - filed by Aurobindo Pharma USA Inc., Aurobindo Pharma, Ltd., Aurobindo Pharma Limited, Aurobindo Pharma USA, Inc.. (Ormerod, Eve) |
| Oct 6, 2020 | 20 | Notice (Other) (2) Docket Text: Amended NOTICE of Deposition of Nurit Perlman by Merck Sharp & Dohme Corp. (Silver, Daniel) |
| Oct 5, 2020 | 18 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of 1) produced their Core Technical Documents Pursuant to Paragraph 4(b) of the Default Standard, 2) produced the DMF for the Sitagliptin API used in its ANDA Product pursuant to Paragraph 3(c)(ii) of the Scheduling Order, and 3) disclosed to Plaintiff whether Aurobindo could produce reasonable quantities of unexpired samples of Aurobindos ANDA Products and API. filed by Aurobindo Pharma USA Inc., Aurobindo Pharma, Ltd., Aurobindo Pharma Limited, Aurobindo Pharma USA, Inc..(Ormerod, Eve) |
| Oct 5, 2020 | 19 | Notice of Service (10) Docket Text: NOTICE OF SERVICE of Plaintiff Merck Sharp & Dohme Corp.'s Responses and Objections to Defendants' Second Set of Joint Interrogatories (Nos. 11-13) filed by Merck Sharp & Dohme Corp..(Joyce, Alexandra) |
| Oct 2, 2020 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Alexander S. Zolan for Merck Sharp & Dohme Corp. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. Associated Cases: 1:20-cv-00749-RGA et al.(kmd) |
| Sep 30, 2020 | 17 | Answer to Counterclaim (7) Docket Text: ANSWER to [10] Answer to Complaint, Counterclaim by Merck Sharp & Dohme Corp..(Silver, Daniel) |
| Sep 29, 2020 | N/A | Case Referred to Mediation (0) Docket Text: CASE REFERRED to Chief Magistrate Judge Mary Pat Thynge for Mediation. Please see Standing Order dated January 20, 2016, regarding disclosure of confidential ADR communications. A link to the standing order is provided here for your convenience at https://www.ded.uscourts.gov/sites/ded/files/forms/StandingOrderforADR-Mediation.pdf Associated Cases: 1:20-cv-00949-RGA, 1:20-cv-01099-RGA(cak) |
| Sep 29, 2020 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Bruce R. Genderson for Merck Sharp & Dohme Corp. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers.Associated Cases: 20-cv-1227-RGA; 20-cv-1099-RGA; 20-cv-776-RGA; 20-cv-815-RGA; 20-cv-749-RGA; 20-cv-847-RGA; 20-cv-949-RGA (myr) |
| Sep 29, 2020 | N/A | Oral Order (0) Docket Text: ORAL ORDER: This matter has been referred to Chief Magistrate Judge Mary Pat Thynge for ADR. Counsel are to advise on or before 10/20/20 by a JOINT EMAIL to Judge Thynge, with a copy to her Judicial Administrator, Ms. Kennedy, their clients interest in mediation and the timing when mediation is preferred with a very brief explanation why. When referencing the timing for mediation, counsel rely on certain events in the scheduling order, for example, before claim construction briefing, after the close of discovery, before expert reports and the like, they are to include the date(s) on when such event(s) occur. Ordered by Chief Magistrate Judge Mary Pat Thynge on 9/29/20. Associated Cases: 1:20-cv-00949-RGA, 1:20-cv-01099-RGA(cak) |
| Sep 28, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (9 in 20-cv-1227-RGA; 11 in 20-cv-1099-RGA; 30 in 20-cv-776-RGA; 19 in 20-cv-815-RGA; 21 in 20-cv-749-RGA; 19 in 20-cv-847-RGA; 12 in 20-cv-949-RGA)MOTION for Pro Hac Vice Appearance of Attorney Bruce R. Genderson, Jessamyn S. Berniker, Stanley E. Fisher, Alexander S. Zolan, Elise Baumgarten, Shaun P. Mahaffy, Anthony H. Sheh, and Jingyuan Luo, filed by Merck Sharp & Dohme Corp.. Signed by Judge Richard G. Andrews on 9/28/2020. Associated Cases: 1:20-cv-00749-RGA et al.(nms) |
| Sep 28, 2020 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Anthony H. Sheh for Merck Sharp & Dohme Corp. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. Associated Cases: 1:20-cv-00749-RGA et al.(kmd) |
| Sep 28, 2020 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Jingyuan Luo for Merck Sharp & Dohme Corp. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. Associated Cases: 1:20-cv-00749-RGA et al.(kmd) |
| Sep 28, 2020 | 12 | Main Document (3) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Bruce R. Genderson, Jessamyn S. Berniker, Stanley E. Fisher, Alexander S. Zolan, Elise Baumgarten, Shaun P. Mahaffy, Anthony H. Sheh, and Jingyuan Luo - filed by Merck Sharp & Dohme Corp.. (Attachments: # (1) Certifications for Bruce R. Genderson, Jessamyn S. Berniker, Stanley E. Fisher, Alexander S. Zolan, Elise Baumgarten, Shaun P. Mahaffy, Anthony H. Sheh, and Jingyuan Luo)(Silver, Daniel) |
| Sep 28, 2020 | 12 | Certifications for Bruce R. Genderson, Jessamyn S. Berniker, Stanley E. Fisher, (8) |
| Sep 28, 2020 | 13 | Scheduling Order (10) Docket Text: SCHEDULING ORDER: Case referred to the Magistrate Judge for the purpose of exploring ADR. Joinder of Parties due by 1/22/2021. Amended Pleadings due by 1/22/2021. Fact Discovery completed by 1/22/2021. A Pretrial Conference is set for 9/10/2021, at 9:00 AM in Courtroom 6A. A 3 day Bench Trial is set to start 10/4/2021, at 8:30 AM in Courtroom 6A (see Order for further details). Signed by Judge Richard G. Andrews on 9/28/2020. Associated Cases: 1:19-md-02902-RGA, 1:20-cv-00949-RGA, 1:20-cv-01099-RGA(nms) |
| Sep 28, 2020 | 14 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of (1) Plaintiffs Initial Disclosures Pursuant to Rule 26(a)(1) of the Federal Rules of Civil Procedure and Paragraph 3 of the Delaware Default Standard for Discovery; and (2) Plaintiffs Initial Disclosures Identifying Defendants Accused Products and Plaintiffs Asserted Patents filed by Merck Sharp & Dohme Corp..(Silver, Daniel) |
| Sep 28, 2020 | 15 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of 1) Default Standard Paragraph 3 Initial Disclosures and 2) Rule 26 Initial Disclosures filed by Aurobindo Pharma USA Inc., Aurobindo Pharma, Ltd., Aurobindo Pharma Limited, Aurobindo Pharma USA, Inc..(Ormerod, Eve) |
| Sep 25, 2020 | 11 | Proposed Order (10) Docket Text: PROPOSED Scheduling Order, by Merck Sharp & Dohme Corp.. (Silver, Daniel) Modified on 9/28/2020 (nms). |
| Sep 16, 2020 | 10 | Answer to Complaint (27) Docket Text: Amended ANSWER to [1] Complaint, and Additional Defenses, and COUNTERCLAIMS against Merck Sharp & Dohme Corp., by Aurobindo Pharma USA, Inc., Aurobindo Pharma Limited.(Belgam, Neal) Modified on 9/16/2020 (nms). |
| Aug 26, 2020 | 8 | Answer to Complaint (27) Docket Text: ANSWER to [1] Complaint, Additional Defenses, and COUNTERCLAIMS against Merck Sharp & Dohme Corp., by Aurobindo Pharma USA, Inc., Aurobindo Pharma Limited.(Ormerod, Eve) Modified on 8/27/2020 (nms). |
| Aug 26, 2020 | 9 | Disclosure Statement (1) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Aurobindo Pharma Ltd. for Aurobindo Pharma USA, Inc. filed by Aurobindo Pharma Limited, Aurobindo Pharma USA, Inc.. (Ormerod, Eve) |
| Aug 20, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [7] STIPULATION TO EXTEND TIME to Answer, Move, or Otherwise Respond to Complaint to August 26, 2020 (*Reset Answer Deadlines: Aurobindo Pharma Limited answer due 8/26/2020; Aurobindo Pharma USA, Inc. answer due 8/26/2020). Signed by Judge Richard G. Andrews on 8/20/2020. (nms) |
| Aug 20, 2020 | 7 | Stipulation to EXTEND Time (1) Docket Text: STIPULATION TO EXTEND TIME to Answer, Move, or Otherwise Respond to Complaint to August 26, 2020 - filed by Aurobindo Pharma Limited, Aurobindo Pharma USA, Inc.. (Ormerod, Eve) |
| Jul 23, 2020 | 6 | Declaration (2) Docket Text: DECLARATION of Service regarding Defedants Aurobindo Pharma Limited and Aurobindo Pharma USA, Inc. made on July 23, 2020, by Merck Sharp & Dohme Corp.. (Joyce, Alexandra) Modified on 7/23/2020 (nms). |
| Jul 22, 2020 | N/A | Case Assigned/Reassigned (0) Docket Text: Case Assigned to Judge Richard G. Andrews. Please include the initials of the Judge (RGA) after the case number on all documents filed. (rjb) |
| Jul 15, 2020 | N/A | No Summons Issued (0) Docket Text: No Summons Issued. (sam) |
| Jul 15, 2020 | 1 | Main Document (11) Docket Text: COMPLAINT filed against Aurobindo Pharma Limited, Aurobindo Pharma USA, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number ADEDC-3063422.)- filed by Merck Sharp & Dohme Corp. (Attachments: # (1) Exhibit A, # (2) Civil Cover Sheet)(sam) |
| Jul 15, 2020 | 1 | Exhibit A (17) |
| Jul 15, 2020 | 1 | Civil Cover Sheet (3) |
| Jul 15, 2020 | 2 | Magistrate Consent Forms (3) Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (sam) |
| Jul 15, 2020 | 3 | Patent/Trademark Report to Commissioner (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,326,708. (sam) |
| Jul 15, 2020 | 4 | ANDA Form (2) Docket Text: Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 06/10/2020. Date of Expiration of Patent: 11/24/2026.Thirty Month Stay Deadline: 12/10/2022. (sam) |
| Jul 15, 2020 | 5 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Merck & Co., Inc. for Merck Sharp & Dohme Corp. filed by Merck Sharp & Dohme Corp. (sam) |
| Jul 15, 2020 | 1 | Complaint* (1) |
